Jordan L. Meier

5.6k total citations · 2 hit papers
88 papers, 3.3k citations indexed

About

Jordan L. Meier is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Jordan L. Meier has authored 88 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Molecular Biology, 15 papers in Pharmacology and 12 papers in Organic Chemistry. Recurrent topics in Jordan L. Meier's work include RNA and protein synthesis mechanisms (21 papers), RNA modifications and cancer (21 papers) and Microbial Natural Products and Biosynthesis (13 papers). Jordan L. Meier is often cited by papers focused on RNA and protein synthesis mechanisms (21 papers), RNA modifications and cancer (21 papers) and Microbial Natural Products and Biosynthesis (13 papers). Jordan L. Meier collaborates with scholars based in United States, Israel and France. Jordan L. Meier's co-authors include Kellie D. Nance, Michael D. Burkart, David C. Montgomery, Peter B. Dervan, Thomas Zengeya, Alexander W. Sorum, Þorkell Andrésson, Stephen D. Fox, Daniel Arango and Shalini Oberdoerffer and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jordan L. Meier

85 papers receiving 3.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Acetylation of Cytidine in mRNA Promotes Translation Efficiency

2018 566 citations Daniel Arango, Mariana D. Mandler et al. profile →
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines

2021 283 citations Kellie D. Nance, Jordan L. Meier profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jordan L. Meier United States	33	2.8k	547	327	307	287	88	3.3k
Xianzhang Bu China	31	2.0k 0.7×	560 1.0×	608 1.9×	275 0.9×	601 2.1×	103	3.3k
Zheng Cui United States	27	1.8k 0.6×	213 0.4×	136 0.4×	235 0.8×	183 0.6×	60	2.9k
Rong‐Guang Shao China	32	1.8k 0.7×	374 0.7×	219 0.7×	264 0.9×	585 2.0×	120	2.8k
Ganesha Rai United States	26	1.3k 0.5×	142 0.3×	311 1.0×	151 0.5×	175 0.6×	90	2.2k
Rilei Yu China	25	1.6k 0.6×	165 0.3×	262 0.8×	186 0.6×	159 0.6×	128	2.4k
Takeo Usui Japan	36	2.0k 0.7×	224 0.4×	1.1k 3.2×	773 2.5×	387 1.3×	149	3.7k
Yiqing Yang China	23	1.6k 0.6×	549 1.0×	362 1.1×	50 0.2×	530 1.8×	60	2.8k
Gyoonhee Han South Korea	30	1.5k 0.5×	208 0.4×	886 2.7×	236 0.8×	474 1.7×	123	2.8k
Cosetta Bertoli United Kingdom	16	1.8k 0.7×	456 0.8×	121 0.4×	132 0.4×	731 2.5×	20	3.0k
Masashi Fujita Japan	25	664 0.2×	272 0.5×	234 0.7×	71 0.2×	253 0.9×	90	1.9k

Countries citing papers authored by Jordan L. Meier

Since Specialization

Citations

This map shows the geographic impact of Jordan L. Meier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan L. Meier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan L. Meier more than expected).

Fields of papers citing papers by Jordan L. Meier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordan L. Meier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan L. Meier. The network helps show where Jordan L. Meier may publish in the future.

Co-authorship network of co-authors of Jordan L. Meier

This figure shows the co-authorship network connecting the top 25 collaborators of Jordan L. Meier. A scholar is included among the top collaborators of Jordan L. Meier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordan L. Meier. Jordan L. Meier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xiyuan, Carly M. Sayers, Wendy Fang, et al.. (2025). MYCN and KAT2A form a feedforward loop to drive an oncogenic transcriptional program in neuroblastoma. Oncogenesis. 14(1). 13–13.

Brodsky, Oleg, Patrick Bingham, Wade Diehl, et al.. (2025). Modulation of the substrate preference of a MYST acetyltransferase by a scaffold protein. Journal of Biological Chemistry. 301(3). 108262–108262. 1 indexed citations

Gamage, Supuni Thalalla, Aldema Sas‐Chen, Ronit Nir, et al.. (2025). A sequence-specific RNA acetylation catalyst. Nucleic Acids Research. 53(6).

Xiong, Ying, Anver Basha Shaik, Kiall F. Suazo, et al.. (2024). Paralogue-Selective Degradation of the Lysine Acetyltransferase EP300. SHILAP Revista de lepidopterología. 4(8). 3094–3103. 1 indexed citations

Mandler, Mariana D., Supuni Thalalla Gamage, Lisa M. Jenkins, et al.. (2024). Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma. NAR Cancer. 6(1). zcae004–zcae004. 8 indexed citations

Kales, Stephen C., Natarajan V. Bhanu, Ying Xiong, et al.. (2023). Comparative Analysis of Drug-like EP300/CREBBP Acetyltransferase Inhibitors. ACS Chemical Biology. 18(10). 2249–2258. 4 indexed citations

Crooks, Daniel R., Christopher J. Ricketts, Cathy D. Vocke, et al.. (2023). Cryptic splice mutation in the fumarate hydratase gene in patients with clinical manifestations of Hereditary Leiomyomatosis and Renal Cell Cancer. Human Molecular Genetics. 32(22). 3135–3145. 1 indexed citations

Megill, Emily, et al.. (2023). Chemoproteomics Yields a Selective Molecular Host for Acetyl-CoA. Journal of the American Chemical Society. 145(30). 16899–16905. 4 indexed citations

Head, PamelaSara E., Jordan L. Meier, & Charles P. Venditti. (2023). New insights into the pathophysiology of methylmalonic acidemia. Journal of Inherited Metabolic Disease. 46(3). 436–449. 11 indexed citations

10.

Bartee, David, Kellie D. Nance, & Jordan L. Meier. (2022). Site-Specific Synthesis of N ⁴ -Acetylcytidine in RNA Reveals Physiological Duplex Stabilization. Journal of the American Chemical Society. 144(8). 3487–3496. 42 indexed citations

11.

Wagner, Gregory R., Kristin A. Anderson, Scott B. Crown, et al.. (2022). Statin therapy inhibits fatty acid synthase via dynamic protein modifications. Nature Communications. 13(1). 2542–2542. 18 indexed citations

12.

Varner, Erika L., Sophie Trefely, David Bartee, et al.. (2020). Quantification of lactoyl-CoA (lactyl-CoA) by liquid chromatography mass spectrometry in mammalian cells and tissues. Open Biology. 10(9). 200187–200187. 100 indexed citations

13.

Kulkarni, Rhushikesh A., Daniel W. Bak, Darmood Wei, et al.. (2019). A chemoproteomic portrait of the oncometabolite fumarate. Nature Chemical Biology. 15(4). 391–400. 78 indexed citations

14.

Cha, Jaepyeong, Roger R. Nani, Michael Luciano, et al.. (2018). A chemically stable fluorescent marker of the ureter. Bioorganic & Medicinal Chemistry Letters. 28(16). 2741–2745. 48 indexed citations

15.

Thomas, Justin M., Chloe A. Briney, Kellie D. Nance, et al.. (2018). A Chemical Signature for Cytidine Acetylation in RNA. Journal of the American Chemical Society. 140(40). 12667–12670. 81 indexed citations

16.

Shrimp, Jonathan H., Tuğsan Tezil, Alexander W. Sorum, et al.. (2017). Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes. Molecular Pharmaceutics. 15(3). 729–736. 4 indexed citations

17.

Dahlin, Jayme L., Kathryn M. Nelson, Jessica M. Strasser, et al.. (2017). Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors. Nature Communications. 8(1). 1527–1527. 77 indexed citations

18.

Shirakawa, Kotaro, Lan Wang, Na Man, et al.. (2016). Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity. eLife. 5. 55 indexed citations

19.

Meier, Jordan L. & Michael D. Burkart. (2009). The chemical biology of modular biosynthetic enzymes. Chemical Society Reviews. 38(7). 2012–2012. 119 indexed citations

20.

Meier, Jordan L., et al.. (2008). The unusual macrocycle forming thioesterase of mycolactone. Molecular BioSystems. 4(6). 663–671. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact